Shopping Cart 0
Cart Subtotal
AED 0

DURECT Corp (DRRX) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 1376

Details

DURECT Corp (DRRX)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

DURECT Corp (Durect) is a specialty pharmaceutical company. It develops pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. The company's major products include Alzet, an osmotic pump; and Lactel, a biodegradable polymer. The company's product pipeline comprises DUR-928 indicated for treatment of acute organ injuries and metabolic/lipid disorders; Posimir, indicated for post-operative pain; Oradur, indicated for chronic pain and attention deficit hyperactivity disorder; and sustained-release ophthalmology product. Durect's major drug delivery technology platforms include Saber, Cloud and Oradur. The company operates in the US, Europe, Japan and other countries. Durect is headquartered in Cupertino, California, the US.

DURECT Corp Key Recent Developments

May 07,2019: DURECT announces first quarter 2019 financial results and update of programs

Apr 25,2019: DURECT appoints two new board members

Mar 07,2019: DURECT Announces Fourth Quarter and Full Year 2018 Financial Results and Update of Programs

Dec 17,2018: DURECT announces retirement of Dr. Felix Theeuwes as chairman of the board and distinguished scientist

Oct 01,2018: DURECT names Michael H. Arenberg as Chief Financial Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

DURECT Corp-Key Facts

DURECT Corp-Key Employees

DURECT Corp-Key Employee Biographies

DURECT Corp-Major Products and Services

DURECT Corp-History

DURECT Corp-Company Statement

DURECT Corp-Locations And Subsidiaries

Head Office

Section 2-Company Analysis

Company Overview

DURECT Corp-Business Description

Geographical Segment: Europe

Performance

Geographical Segment: Japan

Performance

Geographical Segment: Other

Performance

Geographical Segment: United States

Performance

DURECT Corp-Corporate Strategy

DURECT Corp-SWOT Analysis

SWOT Analysis-Overview

DURECT Corp-Strengths

DURECT Corp-Weaknesses

DURECT Corp-Opportunities

DURECT Corp-Threats

DURECT Corp-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

DURECT Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

DURECT Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019

DURECT Corp, Recent Deals Summary

Section 5-Company's Recent Developments

May 07, 2019: DURECT announces first quarter 2019 financial results and update of programs

Apr 25, 2019: DURECT appoints two new board members

Mar 07, 2019: DURECT Announces Fourth Quarter and Full Year 2018 Financial Results and Update of Programs

Dec 17, 2018: DURECT announces retirement of Dr. Felix Theeuwes as chairman of the board and distinguished scientist

Oct 01, 2018: DURECT names Michael H. Arenberg as Chief Financial Officer

Oct 01, 2018: DURECT names Michael H. Arenberg, J.D., M.B.A. as Chief Financial Officer

Sep 30, 2018: DURECT announces third quarter 2018 financial results and provides corporate update

Aug 01, 2018: DURECT announces second quarter 2018 financial results and provides corporate update

May 02, 2018: DURECT Reports First Quarter 2018 Financial Results

Mar 01, 2018: DURECT Announces Fourth Quarter and Full Year 2017 Financial Results and Update of Programs

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

DURECT Corp, Performance Chart (2014-2018)

DURECT Corp, Ratio Charts

DURECT Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

DURECT Corp, Medical Equipment, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

DURECT Corp, Key Facts

DURECT Corp, Key Employees

DURECT Corp, Key Employee Biographies

DURECT Corp, Major Products and Services

DURECT Corp, History

DURECT Corp, Key Competitors

DURECT Corp, Ratios based on current share price

DURECT Corp, Annual Ratios

DURECT Corp, Annual Ratios (Cont...1)

DURECT Corp, Interim Ratios

DURECT Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

DURECT Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019

DURECT Corp, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

DURECT Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Purdue Pharma LP

Pernix Therapeutics Holdings Inc

Pacira BioSciences Inc

Medtronic Plc

MallInckrodt Plc

Knoll Inc

Immune Pharmaceuticals Inc

Eli Lilly and Co

Egalet Corp

Cumberland Pharmaceuticals Inc

Avadel Pharmaceuticals Plc

AstraZeneca Plc

Acorda Therapeutics Inc

AbbVie Inc

DURECT Corp (DRRX)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

DURECT Corp (Durect) is a specialty pharmaceutical company. It develops pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. The company's major products include Alzet, an osmotic pump; and Lactel, a biodegradable polymer. The company's product pipeline comprises DUR-928 indicated for treatment of acute organ injuries and metabolic/lipid disorders; Posimir, indicated for post-operative pain; Oradur, indicated for chronic pain and attention deficit hyperactivity disorder; and sustained-release ophthalmology product. Durect's major drug delivery technology platforms include Saber, Cloud and Oradur. The company operates in the US, Europe, Japan and other countries. Durect is headquartered in Cupertino, California, the US.

DURECT Corp Key Recent Developments

May 07,2019: DURECT announces first quarter 2019 financial results and update of programs

Apr 25,2019: DURECT appoints two new board members

Mar 07,2019: DURECT Announces Fourth Quarter and Full Year 2018 Financial Results and Update of Programs

Dec 17,2018: DURECT announces retirement of Dr. Felix Theeuwes as chairman of the board and distinguished scientist

Oct 01,2018: DURECT names Michael H. Arenberg as Chief Financial Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

DURECT Corp-Key Facts

DURECT Corp-Key Employees

DURECT Corp-Key Employee Biographies

DURECT Corp-Major Products and Services

DURECT Corp-History

DURECT Corp-Company Statement

DURECT Corp-Locations And Subsidiaries

Head Office

Section 2-Company Analysis

Company Overview

DURECT Corp-Business Description

Geographical Segment: Europe

Performance

Geographical Segment: Japan

Performance

Geographical Segment: Other

Performance

Geographical Segment: United States

Performance

DURECT Corp-Corporate Strategy

DURECT Corp-SWOT Analysis

SWOT Analysis-Overview

DURECT Corp-Strengths

DURECT Corp-Weaknesses

DURECT Corp-Opportunities

DURECT Corp-Threats

DURECT Corp-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

DURECT Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

DURECT Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019

DURECT Corp, Recent Deals Summary

Section 5-Company's Recent Developments

May 07, 2019: DURECT announces first quarter 2019 financial results and update of programs

Apr 25, 2019: DURECT appoints two new board members

Mar 07, 2019: DURECT Announces Fourth Quarter and Full Year 2018 Financial Results and Update of Programs

Dec 17, 2018: DURECT announces retirement of Dr. Felix Theeuwes as chairman of the board and distinguished scientist

Oct 01, 2018: DURECT names Michael H. Arenberg as Chief Financial Officer

Oct 01, 2018: DURECT names Michael H. Arenberg, J.D., M.B.A. as Chief Financial Officer

Sep 30, 2018: DURECT announces third quarter 2018 financial results and provides corporate update

Aug 01, 2018: DURECT announces second quarter 2018 financial results and provides corporate update

May 02, 2018: DURECT Reports First Quarter 2018 Financial Results

Mar 01, 2018: DURECT Announces Fourth Quarter and Full Year 2017 Financial Results and Update of Programs

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

DURECT Corp, Performance Chart (2014-2018)

DURECT Corp, Ratio Charts

DURECT Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

DURECT Corp, Medical Equipment, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

DURECT Corp, Key Facts

DURECT Corp, Key Employees

DURECT Corp, Key Employee Biographies

DURECT Corp, Major Products and Services

DURECT Corp, History

DURECT Corp, Key Competitors

DURECT Corp, Ratios based on current share price

DURECT Corp, Annual Ratios

DURECT Corp, Annual Ratios (Cont...1)

DURECT Corp, Interim Ratios

DURECT Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

DURECT Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019

DURECT Corp, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

DURECT Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Purdue Pharma LP

Pernix Therapeutics Holdings Inc

Pacira BioSciences Inc

Medtronic Plc

MallInckrodt Plc

Knoll Inc

Immune Pharmaceuticals Inc

Eli Lilly and Co

Egalet Corp

Cumberland Pharmaceuticals Inc

Avadel Pharmaceuticals Plc

AstraZeneca Plc

Acorda Therapeutics Inc

AbbVie Inc